Supriya Lifescience

Sector: Healthcare

Followers

5
5
7
7
.
8
8
3
3
6
6
10.20 (1.62%)

As on 10 Apr, 2026 | 15:59

Open Trading A/c
Day Range
631.65
645.00
LH
52 Week Range
545.50
832.40
LH
Volume
* i
Bid / Ask
57,243.00
638.75 / 363.00

Supriya Lifescience Announcements

Enclosed herewith is the Certificate under Regulation 74 (5) of SEBI (Depository and Participants) Regulation, 2018 for the quarter ended March 31, 2026.Kindly take the...

10 Apr, 2026 | 12:24pm • Source: BSE

Intimation for Closure of Trading Window for declaration of Audited Financial Results for quarter and year ending March 31, 2026 is enclosed herewith.Kindly take the...

25 Mar, 2026 | 04:38pm • Source: BSE

Enclosed herewith are the details of Change in Management with regards to completion of tenure of Independent Directors of the Company.Kindly take the same on...

24 Mar, 2026 | 05:41pm • Source: BSE

Transcript of the Earnings Call for the Unaudited Financial Results for quarter and nine months ended December 31, 2025, is enclosed herewith.Kindly take the same...

17 Feb, 2026 | 10:51am • Source: BSE

Audio Recording of the Earnings Call for Unaudited Financial Results of quarter and nine months ended December 31, 2025 is enclosed herewith.

10 Feb, 2026 | 04:25pm • Source: BSE

Supriya Lifescience Limited has informed the Exchange regarding a press release dated February 10, 2026, titled "Press Release- Unaudited Financial Results for the Quarter and...

10 Feb, 2026 | 01:24pm • Source: NSE

Newspaper Publication of Unaudited Financial Results for the quarter and nine months ended December 31, 2025 is enclosed.

10 Feb, 2026 | 01:11pm • Source: BSE

Press Release for Unaudited Financial Results for quarter and nine months ended December 31, 2025 is enclosed.

10 Feb, 2026 | 01:06pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...

09 Feb, 2026 | 07:18pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...

04 Feb, 2026 | 12:46pm • Source: BSE

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and...

02 Feb, 2026 | 05:37pm • Source: BSE

Certificate under Regulation 74 (5) of SEBI (Depositories & Participants) Regulations, 2018 for quarter ended December 31, 20205 is enclosed.

06 Jan, 2026 | 04:12pm • Source: BSE

Intimation on Credit Rating to the Company is enclosed.

30 Dec, 2025 | 03:40pm • Source: BSE

Intimation for Closure of Trading Window for declaration of the Unaudited Financial Results for quarter and nine months ending on December 31, 2025.Kindly take the...

28 Dec, 2025 | 11:36pm • Source: BSE

Transcript of the Earnings Call for the Unaudited Financial Results for the quarter and half year ended September 30, 2025, is enclosed herewith.Kindly take the...

18 Nov, 2025 | 10:48am • Source: BSE

Investor Presentation is enclosed herewith.

12 Nov, 2025 | 06:02pm • Source: BSE

Unaudited Financial Results for the Quarter and Half year ended September 30,2025 are enclosed herewith.Kindly take the same on record.

12 Nov, 2025 | 05:25pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors of the...

12 Nov, 2025 | 05:10pm • Source: BSE

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held...

09 Nov, 2025 | 11:17pm • Source: BSE

Supriya Lifescience Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and...

05 Nov, 2025 | 08:31pm • Source: BSE